FluoGuide A/S

FluoGuide A/S

Intelligent surgical targeting - light up cancer and increase surgical precision

Founded 2018 Denmark

Denmark 14 employees Post-IPO Equity Total: $252.50M Biotechnology, Health Care

FluoGuide, a Danish biotech startup founded in 2018, is making waves in the field of precision cancer surgery. Its flagship product, FG001, is a groundbreaking solution designed to improve surgical accuracy in cancer treatment. By using fluorescent light that binds to the widely expressed uPAR receptor in most solid cancer types, FG001 illuminates cancer cells intraoperatively, thus enhancing precision during surgery. The company anticipates that the use of FG001 will not only reduce the incidence of local recurrence after surgery and surgical complications but also ultimately lead to better treatment outcomes for patients while decreasing healthcare costs. Moreover, FluoGuide's innovative technology platform has the potential for broader applications, including photothermal therapy (PTT), which targets and kills cancer cells using near-infrared light. This technique has the added benefit of sparing healthy surrounding tissue from damage, thus directly contributing to improved patient outcomes. With a recent kr250.00M Post-IPO Equity investment by OP Financial Group, Linc AB, and Arbejdernes Landsbank on 10 March 2022, FluoGuide is poised for further growth and development. As a testament to its progress, FluoGuide is listed on the Nasdaq First North Growth Market in Stockholm under the ticker symbol "FLUO." For more information about FluoGuide's pipeline, technology, and upcoming events, visit www.fluoguide.com.

Funding Stage	Amount	Investors	Lead Investors	Date
Post IPO Equity	kr250.00M	3	OP Financial Group, Linc AB +1	10 Mar 2022
Grant	€2.50M	1	European Innovation Council	08 Jun 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Post IPO Equity

kr250.00M

OP Financial Group, Linc AB +1

10 Mar 2022

Grant

€2.50M

European Innovation Council

08 Jun 2020

FAQ About FluoGuide A/S

Intelligent surgical targeting - light up cancer and increase surgical precision

FluoGuide A/S was founded in 2018.

FluoGuide A/S is headquartered in Denmark.

FluoGuide A/S operates in Biotechnology and Health Care. Its work centres on precision surgery, cancer treatment, surgical targeting and oncology.

FluoGuide A/S has approximately 14 employees.

FluoGuide A/S has completed 2 funding rounds, raising a total of $252.50M. The latest funding stage is Post-IPO Equity.

Top alternatives and competitors to FluoGuide A/S include The Royal Marsden NHS Foundation Trust, Coeptis Therapeutics, OncoSynergy, Madison Vaccines, Endocyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

FluoGuide A/S and The Royal Marsden NHS Foundation Trust are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About FluoGuide A/S

Funding Rounds & Investors (2)

FluoGuide A/S Alternatives & Competitors

FAQ About FluoGuide A/S